InsiderTrades.com logo
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
From Paradigm Press   |   Ad
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
Click here to find out that this 8,788% cryptocurrency is.

NVC Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$0.00

Neovasc Insider Trading History Chart

This chart shows the insider buying and selling history at Neovasc by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Neovasc Share Price & Price History

Current Price: C$0.00
Price Change: +0.30 (1.20%)
As of 03/10/2017 09:06 PM ET

This chart shows the closing price history over time for NVC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
This Apple-like Innovator is Revolutionizing Healthcare
From Wall Street Star   |   Ad
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Click here to learn more about the booming eHealth industry

Neovasc Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2022Paul GeyerDirectorBuy3,000C$8.71C$26,130.0018,335
10/12/2022Paul GeyerDirectorBuy2,783C$6.50C$18,089.5015,335
10/7/2022Paul GeyerDirectorBuy2,217C$8.39C$18,589.5512,552
9/22/2022Paul GeyerDirectorBuy2,271C$8.13C$18,456.428,742
9/16/2022Paul GeyerDirectorBuy4,486C$8.39C$37,615.114,486
8/19/2022Doug JanzenDirectorBuy10,000C$9.84C$98,428.2938,779
7/22/2022Doug JanzenDirectorBuy1,645C$7.78C$12,800.2128,779
7/13/2022Doug JanzenDirectorBuy2,280C$7.75C$17,677.0024,834
7/5/2022Doug JanzenDirectorBuy1,271C$7.67C$9,745.0722,416
6/30/2022Doug JanzenDirectorBuy338C$7.74C$2,616.1221,145
6/22/2022Chris ClarkSenior OfficerSell98C$7.66C$750.3948,997
6/22/2022Doug JanzenDirectorBuy2,743C$7.60C$20,843.4016,895
6/8/2022Paul GeyerDirectorSell4,933C$7.20C$35,517.60
6/6/2022Chris ClarkSenior OfficerSell628C$6.75C$4,241.2648,868
6/6/2022Chris ClarkSenior OfficerSell628C$6.75C$4,241.2648,868
2/20/2022Chris ClarkSenior OfficerSell6,242C$0.58C$3,595.3948,578
8/19/2021Doug JanzenDirectorBuy100,000C$1.00C$99,712.80330,453
6/29/2021Doug JanzenDirectorBuy100,000C$1.24C$123,525.60230,453
6/21/2021Doug JanzenDirectorBuy48,398C$1.15C$55,580.2678,851
See Full Table
This Apple-like Innovator is Revolutionizing Healthcare
From Wall Street Star   |   Ad
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Click here to learn more about the booming eHealth industry

SEC Filings (Institutional Ownership Changes) for Neovasc (TSE:NVC)

Neovasc logo
Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.
Read More on Neovasc

Today's Range

Now: N/A

50 Day Range

MA: C$1.78
Low: C$1.78
High: C$1.78

52 Week Range

Now: N/A

Volume

46,869 shs

Average Volume

111,876 shs

Market Capitalization

C$140.06 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Neovasc?

Neovasc's top insider investors include:
  1. Chris Clark (Senior Officer)
  2. Doug Janzen (Director)
  3. Paul Geyer (Director)
Learn More about top insider investors at Neovasc.
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
From Paradigm Press   |   Ad
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
Click here to find out that this 8,788% cryptocurrency is.